New insider activity at Guardian Pharmacy Services, Inc. Class A ( (GRDN) ) has taken place on September 30, 2025.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Recently, significant transactions occurred involving the stock of Guardian Pharmacy Services, Inc. Class A. Cardinal Equity Fund, L.P., a member of the 10% owner group, sold 321,263 shares, generating $6,476,662. Additionally, Pharmacy Investors, LLC, another member of the 10% owner group, sold 964,316 shares, amounting to $19,440,610. These transactions highlight substantial movements within the company’s stock holdings.
Recent Updates on GRDN stock
In the last 24 hours, Guardian Pharmacy Services, Inc. Class A (GRDN) has seen positive developments that have influenced its stock price. Truist analyst David MacDonald raised the price target for Guardian Pharmacy to $30 from $28, maintaining a Buy rating. This adjustment follows management meetings that highlighted the company’s strong market positioning, robust core demand, and expansion opportunities. Guardian’s recent strategic initiatives in the assisted living facilities (ALF) market, coupled with strong Q2 2025 results, have bolstered investor confidence. The company reported a Q2 adjusted EPS of 23 cents, surpassing estimates, and raised its FY25 revenue outlook to $1.39B-$1.41B, above the consensus of $1.35B. Despite these positive indicators, some analysts express caution due to profitability and leverage challenges, resulting in a mixed overall stock assessment.
Spark’s Take on GRDN Stock
According to Spark, TipRanks’ AI Analyst, GRDN is a Neutral.
Guardian Pharmacy Services, Inc. presents a mixed picture. Strong revenue growth and positive guidance improve the outlook, yet significant profitability and leverage challenges remain. The technical analysis signals a short-term upward trend, but valuation is difficult to assess due to missing key metrics. Overall, the stock’s strengths in growth are countered by financial and valuation uncertainties, resulting in a moderate stock score.
To see Spark’s full report on GRDN stock, click here.
More about Guardian Pharmacy Services, Inc. Class A
YTD Price Performance: 31.07%
Average Trading Volume: 278,171
Technical Sentiment Signal: Strong Buy
Current Market Cap: $1.65B